© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 1.9% of VRPX shares are held by financial institutions. JPMORGAN CHASE & CO is the top corporate investor, holding 0 shares valued at -. A 0% stake in Virpax Pharmaceuticals, Inc. is owned by the company. GEODE CAPITAL MANAGEMENT, LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the VRPX insiders holding of 3.72% of the stake in company, MACK ANTHONY P., Chief Executive Officer, holds the largest shares of 252.56K. SENDROW JERROLD, , is the second largest VRPX insider with ownership of 9.01K shares. FLOYD ERIC, , stands third with possession of 8.02K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own VRPX shares is 10, representing 1.9% of the company's common stock.
JPMORGAN CHASE & CO, in the last quarter, reduced its stake in VRPX by -100% restricting it's holding to 0 shares of worth nearly -. GEODE CAPITAL MANAGEMENT, LLC also lessened -100% of the VRPX shares from its portfolio, reducing its holding to 0 shares of worth -. BLACKROCK INC. also shunned VRPX shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, VANGUARD GROUP INC increased its stake in VRPX by 1.76% in the last quarter. The institutional holder raised its holding to 66.29 thousand shares having worth more than $21.22K. SHEETS SMITH WEALTH MANAGEMENT also added 100% more shares of VRPX to its portfolio, raising its holding to 50 thousand shares of worth $16.01K. TWO SIGMA SECURITIES, LLC also increased its VRPX shares holding by 100% which brought its holding to 11.7 thousand shares worth $3.74K.
The insider with the most stakes in VRPX is Mack Anthony P. , Chief Executive Officer at the company. Additionally, VRPX stock is highly held by Sendrow Jerrold and Floyd Eric among others.
Company executives, directors, and other insiders own 3.72% percent of Virpax Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which VRPX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .
There have been 0 transaction(s) during the past 6-months in which Virpax Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares
Around 0 Virpax Pharmaceuticals, Inc. shares are held by insiders, which represents about 3.72% of VRPX stock.
VRPX Chief Executive Officer, Mack Anthony P. holds the largest portfolio of the company's shares. VRPX shares owned by Mack total nearly 252.56 thousand.
JPMORGAN CHASE & CO is the largest institutional owner in VRPX which holds 0 shares worth - or 0% of the total VRPX shares outstanding followed by GEODE CAPITAL MANAGEMENT, LLC with ownership of 0 shares representing 0% of the VRPX ownership. BLACKROCK INC. is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the VRPX is concerned, it is a stock which is not optionable.
Number of VRPX shares short is 350.86K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 14.89M shares of VRPX are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, VRPX has 4.59M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for VRPX is 1.04.